Spots Global Cancer Trial Database for ribavirin
Every month we try and update this database with for ribavirin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML | NCT02073838 | Acute Myeloid L... | Ribavirin Vismodegib Decitabine | 18 Years - | Jewish General Hospital | |
| Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients | NCT01309490 | Malignant Solid... | Ribavirin | 18 Years - | Jewish General Hospital | |
| A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma | NCT02504099 | Chronic Hepatit... | ombitasvir/pari... ombitasvir/pari... ribavirin | 18 Years - | AbbVie | |
| Respiratory Syncytial Virus - RSV Protocol | NCT01502072 | Bone Marrow Tra... Infection in Ma... Respiratory Syn... Respiratory Syn... Cancer Acute Leukemia | Ribavirin Ribavirin | 18 Years - | M.D. Anderson Cancer Center | |
| Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy | NCT05717400 | Liver Cancer | Bevacizumab Atezolizumab Sofosbuvir Velpatasvir Voxilaprevir Ribavirin | 18 Years - | M.D. Anderson Cancer Center | |
| Treatment With Ribavirin for Patients With Metastatic Breast Cancer | NCT01056757 | Metastatic Brea... | Ribavirin | 18 Years - | Jewish General Hospital | |
| Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia | NCT01056523 | Acute Myeloid L... | Ribavirin Cytarabine arab... | 18 Years - | Jewish General Hospital | |
| Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma | NCT00834860 | Chronic Hepatit... Hepatocellular ... | peginterferon a... | 18 Years - | Kaohsiung Medical University Chung-Ho Memorial Hospital | |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | NCT01559844 | Hepatitis C Hepatocellular ... | Sofosbuvir Ribavirin | 18 Years - | Gilead Sciences | |
| Intermittent Use of Aerosolized Ribavirin for Treatment of RSV | NCT00500578 | Hematological M... | Ribavirin Ribavirin | 5 Years - | M.D. Anderson Cancer Center | |
| Treatment With Ribavirin for Patients With Metastatic Breast Cancer | NCT01056757 | Metastatic Brea... | Ribavirin | 18 Years - | Jewish General Hospital | |
| A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia | NCT00559091 | Acute Myelocyti... | ribavirin | 18 Years - | Jewish General Hospital | |
| Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) | NCT01821963 | Infection | Pegylated Inter... Ribavirin Telaprevir | 18 Years - 69 Years | M.D. Anderson Cancer Center | |
| Respiratory Syncytial Virus - RSV Protocol | NCT01502072 | Bone Marrow Tra... Infection in Ma... Respiratory Syn... Respiratory Syn... Cancer Acute Leukemia | Ribavirin Ribavirin | 18 Years - | M.D. Anderson Cancer Center | |
| A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma | NCT03585725 | Follicular Lymp... Mantle Cell Lym... | Ribavirin | 18 Years - | Weill Medical College of Cornell University | |
| Respiratory Syncytial Virus - RSV Protocol | NCT01502072 | Bone Marrow Tra... Infection in Ma... Respiratory Syn... Respiratory Syn... Cancer Acute Leukemia | Ribavirin Ribavirin | 18 Years - | M.D. Anderson Cancer Center | |
| Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies | NCT02308241 | Human Papilloma... Recurrent/Metas... | Ribavirin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) | NCT01821963 | Infection | Pegylated Inter... Ribavirin Telaprevir | 18 Years - 69 Years | M.D. Anderson Cancer Center | |
| Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML | NCT02073838 | Acute Myeloid L... | Ribavirin Vismodegib Decitabine | 18 Years - | Jewish General Hospital | |
| Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients | NCT01309490 | Malignant Solid... | Ribavirin | 18 Years - | Jewish General Hospital | |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | NCT01559844 | Hepatitis C Hepatocellular ... | Sofosbuvir Ribavirin | 18 Years - | Gilead Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
